Related Experiment Video

Updated: Jun 15, 2026

Interventional Diagnostic Procedure: A Practical Guide for the Assessment of Coronary Vascular Function
10:28

Interventional Diagnostic Procedure: A Practical Guide for the Assessment of Coronary Vascular Function

Published on: March 15, 2022

Preprocedural statin therapy to prevent myocardial damage in percutaneous coronary intervention: a review of

Simona Mega1, Giuseppe Patti, Christopher P Cannon

  • 1Department of Cardiovascular Sciences, Campus Bio-Medico University of Rome, Via Alvaro del Potillo 200, Rome, Italy. s.mega@unicampus.it

Critical Pathways in Cardiology
|March 11, 2010
PubMed

Insights

Pretreating patients with high-dose statins before percutaneous coronary intervention (PCI) significantly reduces heart muscle injury and improves outcomes. This approach is recommended as standard care for patients undergoing PCI.

Area of Science:

  • Cardiology
  • Pharmacology

Background:

  • Statin therapy benefits cardiovascular disease prevention through lipid-lowering and pleiotropic effects.
  • The optimal timing for statin initiation relative to acute cardiovascular events remains unclear.
  • Percutaneous coronary intervention (PCI) can cause myocardial injury, impacting long-term prognosis.

Purpose of the Study:

  • To evaluate the efficacy of statin pretreatment in reducing periprocedural myocardial injury during PCI.
  • To assess the impact of short-term high-dose statin administration on clinical outcomes in patients undergoing coronary procedures.

Main Methods:

  • Review of randomized controlled trials investigating statin pretreatment before elective PCI.
  • Analysis of studies examining short-term high-dose statin use in acute coronary syndromes and high C-reactive protein levels.

Main Results:

  • Statin pretreatment before elective PCI reduces periprocedural myocardial injury in stable angina patients.
  • High-dose statin administration before coronary procedures improves outcomes in acute coronary syndromes and/or high CRP levels.

Conclusions:

  • Evidence supports routine use of high-dose statins as adjuvant therapy before percutaneous coronary revascularization.
  • Statin pretreatment mitigates myocardial injury associated with PCI.

More Related Videos

A Murine Model of Stent Implantation in the Carotid Artery for the Study of Restenosis04:30

A Murine Model of Stent Implantation in the Carotid Artery for the Study of Restenosis

Published on: May 14, 2013

Related Concept Videos

Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
Angina IV: Management01:26

Angina IV: Management

IntroductionThe management of angina requires a comprehensive approach that includes pharmacological therapies, medical procedures, and lifestyle modifications.Pharmacological TherapiesAntiplatelet agents, such as aspirin, clopidogrel, prasugrel, and ticagrelor, play a pivotal role in preventing thrombus formation in patients with angina. These medications inhibit platelet aggregation and reduce the likelihood of myocardial infarction and other cardiovascular events.Anticoagulants, including...
Peripheral Artery Disease III: Interprofessional Care01:27

Peripheral Artery Disease III: Interprofessional Care

Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
Cardiac Catheterization I: Pre-Procedure Overview01:28

Cardiac Catheterization I: Pre-Procedure Overview

Cardiac catheterization is an invasive diagnostic technique used to identify and evaluate structural and functional diseases of the heart and major blood vessels. This technique diagnoses congenital heart disease, coronary artery disease, valvular heart disease, and coronary spasms and assesses ventricular function. It helps guide treatment decisions, including the need for revascularization procedures like percutaneous coronary intervention (PCI) or coronary artery bypass grafting (CABG) and...